Cardiovascular disease
The sponsor’s clinical research is centered on coronary artery disease, with attention to patients undergoing percutaneous coronary intervention in both stable coronary artery disease and acute coronary syndromes.
- Coronary artery disease
- Percutaneous coronary intervention
- Acute coronary syndromes
Its research activity includes care for patients with complex cardiovascular risk profiles, particularly those requiring interventional treatment for obstructive coronary disease.
Interventional cardiology
Clinical interest extends to device-based coronary treatment strategies, including comparison of drug-coated balloon therapy with drug-eluting stents in coronary revascularisation.
- Drug-coated balloon
- Drug-eluting stents
- Coronary revascularisation
This focus places emphasis on selecting interventional approaches suited to patients with high bleeding risk.
Bleeding risk and antithrombotic care
The sponsor is involved in research for patients with elevated bleeding risk and those receiving anticoagulation, with attention to balancing coronary treatment against haemorrhagic complications.
- High bleeding risk
- Anticoagulation
- Dual antiplatelet therapy
Its trial activity reflects interest in shortening dual antiplatelet therapy where clinically appropriate in coronary intervention settings.
